Logo image of BTSGU

BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 (BTSGU) Stock Fundamental Analysis

NASDAQ:BTSGU - Nasdaq - US10950A2050 - Currency: USD

77.21  +0.19 (+0.25%)

Fundamental Rating

4

BTSGU gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 103 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of BTSGU get a neutral evaluation. Nothing too spectacular is happening here. BTSGU is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

BTSGU had positive earnings in the past year.
In the past year BTSGU had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: BTSGU reported negative net income in multiple years.
Of the past 5 years BTSGU 4 years had a positive operating cash flow.
BTSGU Yearly Net Income VS EBIT VS OCF VS FCFBTSGU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

BTSGU has a Return On Assets (0.98%) which is in line with its industry peers.
BTSGU has a Return On Equity (3.39%) which is in line with its industry peers.
BTSGU has a Return On Invested Capital (4.48%) which is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for BTSGU is significantly below the industry average of 9.71%.
The last Return On Invested Capital (4.48%) for BTSGU is above the 3 year average (3.45%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.98%
ROE 3.39%
ROIC 4.48%
ROA(3y)-1.36%
ROA(5y)-0.55%
ROE(3y)-11.56%
ROE(5y)-5.06%
ROIC(3y)3.45%
ROIC(5y)3.56%
BTSGU Yearly ROA, ROE, ROICBTSGU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -10 -20

1.3 Margins

Looking at the Profit Margin, with a value of 0.49%, BTSGU is in line with its industry, outperforming 50.49% of the companies in the same industry.
BTSGU has a Operating Margin of 2.15%. This is comparable to the rest of the industry: BTSGU outperforms 48.54% of its industry peers.
In the last couple of years the Operating Margin of BTSGU has grown nicely.
BTSGU has a worse Gross Margin (13.46%) than 70.87% of its industry peers.
In the last couple of years the Gross Margin of BTSGU has declined.
Industry RankSector Rank
OM 2.15%
PM (TTM) 0.49%
GM 13.46%
OM growth 3Y-19.38%
OM growth 5Y5.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.88%
GM growth 5Y-5.21%
BTSGU Yearly Profit, Operating, Gross MarginsBTSGU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BTSGU is destroying value.
The number of shares outstanding for BTSGU has been increased compared to 1 year ago.
Compared to 5 years ago, BTSGU has more shares outstanding
BTSGU has a better debt/assets ratio than last year.
BTSGU Yearly Shares OutstandingBTSGU Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
BTSGU Yearly Total Debt VS Total AssetsBTSGU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

BTSGU has an Altman-Z score of 4.23. This indicates that BTSGU is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.23, BTSGU is in the better half of the industry, outperforming 75.73% of the companies in the same industry.
The Debt to FCF ratio of BTSGU is 19.98, which is on the high side as it means it would take BTSGU, 19.98 years of fcf income to pay off all of its debts.
BTSGU has a Debt to FCF ratio of 19.98. This is comparable to the rest of the industry: BTSGU outperforms 40.78% of its industry peers.
A Debt/Equity ratio of 1.48 is on the high side and indicates that BTSGU has dependencies on debt financing.
With a Debt to Equity ratio value of 1.48, BTSGU is not doing good in the industry: 71.84% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.48
Debt/FCF 19.98
Altman-Z 4.23
ROIC/WACC0.53
WACC8.5%
BTSGU Yearly LT Debt VS Equity VS FCFBTSGU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

BTSGU has a Current Ratio of 1.73. This is a normal value and indicates that BTSGU is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.73, BTSGU is doing good in the industry, outperforming 61.16% of the companies in the same industry.
BTSGU has a Quick Ratio of 1.37. This is a normal value and indicates that BTSGU is financially healthy and should not expect problems in meeting its short term obligations.
BTSGU has a Quick ratio (1.37) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.73
Quick Ratio 1.37
BTSGU Yearly Current Assets VS Current LiabilitesBTSGU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 122.31% over the past year.
BTSGU shows a small growth in Revenue. In the last year, the Revenue has grown by 1.45%.
Measured over the past years, BTSGU shows a very strong growth in Revenue. The Revenue has been growing by 20.01% on average per year.
EPS 1Y (TTM)122.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.33%
Revenue 1Y (TTM)1.45%
Revenue growth 3Y18.93%
Revenue growth 5Y20.01%
Sales Q2Q%11.7%

3.2 Future

The Earnings Per Share is expected to grow by 29.97% on average over the next years. This is a very strong growth
Based on estimates for the next years, BTSGU will show a small growth in Revenue. The Revenue will grow by 7.63% on average per year.
EPS Next Y54.35%
EPS Next 2Y36.83%
EPS Next 3Y28.67%
EPS Next 5Y29.97%
Revenue Next Year9.72%
Revenue Next 2Y10.92%
Revenue Next 3Y10.94%
Revenue Next 5Y7.63%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BTSGU Yearly Revenue VS EstimatesBTSGU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B
BTSGU Yearly EPS VS EstimatesBTSGU Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 0 0.5 1 1.5 2

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 124.53, BTSGU can be considered very expensive at the moment.
BTSGU's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of BTSGU to the average of the S&P500 Index (27.45), we can say BTSGU is valued expensively.
The Price/Forward Earnings ratio is 74.98, which means the current valuation is very expensive for BTSGU.
The rest of the industry has a similar Price/Forward Earnings ratio as BTSGU.
BTSGU is valuated expensively when we compare the Price/Forward Earnings ratio to 21.90, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 124.53
Fwd PE 74.98
BTSGU Price Earnings VS Forward Price EarningsBTSGU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as BTSGU.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BTSGU indicates a slightly more expensive valuation: BTSGU is more expensive than 60.19% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 105.52
EV/EBITDA 35.7
BTSGU Per share dataBTSGU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
BTSGU's earnings are expected to grow with 28.67% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.29
PEG (5Y)N/A
EPS Next 2Y36.83%
EPS Next 3Y28.67%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.37%, BTSGU is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.42, BTSGU pays a better dividend. On top of this BTSGU pays more dividend than 99.03% of the companies listed in the same industry.
BTSGU's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 4.37%

5.2 History

BTSGU does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
BTSGU Yearly Dividends per shareBTSGU Yearly Dividends per shareYearly Dividends per share 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

DPN/A
EPS Next 2Y36.83%
EPS Next 3Y28.67%
BTSGU Yearly Income VS Free CF VS DividendBTSGU Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27

NASDAQ:BTSGU (7/3/2025, 7:06:15 PM)

77.21

+0.19 (+0.25%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-02 2025-05-02/bmo
Earnings (Next)08-01 2025-08-01/bmo
Inst Owners53.2%
Inst Owner ChangeN/A
Ins Owners2.93%
Ins Owner ChangeN/A
Market Cap13.45B
Analysts84.21
Price Target96.13 (24.5%)
Short Float %0.02%
Short Ratio0.19
Dividend
Industry RankSector Rank
Dividend Yield 4.37%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date07-15 2025-07-15 (0.8437)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)47.16%
Min EPS beat(2)-2.7%
Max EPS beat(2)97.01%
EPS beat(4)1
Avg EPS beat(4)3.84%
Min EPS beat(4)-40.94%
Max EPS beat(4)97.01%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)1.12%
Min Revenue beat(2)-0.62%
Max Revenue beat(2)2.86%
Revenue beat(4)3
Avg Revenue beat(4)2.37%
Min Revenue beat(4)-0.62%
Max Revenue beat(4)4.83%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.09%
PT rev (3m)6.27%
EPS NQ rev (1m)7.14%
EPS NQ rev (3m)39.29%
EPS NY rev (1m)3.33%
EPS NY rev (3m)44.22%
Revenue NQ rev (1m)0.49%
Revenue NQ rev (3m)3.17%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)2.95%
Valuation
Industry RankSector Rank
PE 124.53
Fwd PE 74.98
P/S 1.16
P/FCF 105.52
P/OCF 65.88
P/B 7.97
P/tB N/A
EV/EBITDA 35.7
EPS(TTM)0.62
EY0.8%
EPS(NY)1.03
Fwd EY1.33%
FCF(TTM)0.73
FCFY0.95%
OCF(TTM)1.17
OCFY1.52%
SpS66.39
BVpS9.68
TBVpS-7.18
PEG (NY)2.29
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.98%
ROE 3.39%
ROCE 5.67%
ROIC 4.48%
ROICexc 4.54%
ROICexgc 14.07%
OM 2.15%
PM (TTM) 0.49%
GM 13.46%
FCFM 1.1%
ROA(3y)-1.36%
ROA(5y)-0.55%
ROE(3y)-11.56%
ROE(5y)-5.06%
ROIC(3y)3.45%
ROIC(5y)3.56%
ROICexc(3y)3.47%
ROICexc(5y)3.63%
ROICexgc(3y)17.05%
ROICexgc(5y)18.21%
ROCE(3y)4.37%
ROCE(5y)4.5%
ROICexcg growth 3Y-9.4%
ROICexcg growth 5Y19.06%
ROICexc growth 3Y-3.14%
ROICexc growth 5Y18.48%
OM growth 3Y-19.38%
OM growth 5Y5.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.88%
GM growth 5Y-5.21%
F-Score6
Asset Turnover1.98
Health
Industry RankSector Rank
Debt/Equity 1.48
Debt/FCF 19.98
Debt/EBITDA 5.59
Cap/Depr 38.81%
Cap/Sales 0.66%
Interest Coverage 1.22
Cash Conversion 45.71%
Profit Quality 222.79%
Current Ratio 1.73
Quick Ratio 1.37
Altman-Z 4.23
F-Score6
WACC8.5%
ROIC/WACC0.53
Cap/Depr(3y)36.76%
Cap/Depr(5y)33.73%
Cap/Sales(3y)0.82%
Cap/Sales(5y)0.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)122.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.33%
EPS Next Y54.35%
EPS Next 2Y36.83%
EPS Next 3Y28.67%
EPS Next 5Y29.97%
Revenue 1Y (TTM)1.45%
Revenue growth 3Y18.93%
Revenue growth 5Y20.01%
Sales Q2Q%11.7%
Revenue Next Year9.72%
Revenue Next 2Y10.92%
Revenue Next 3Y10.94%
Revenue Next 5Y7.63%
EBIT growth 1Y60.42%
EBIT growth 3Y-4.13%
EBIT growth 5Y26.66%
EBIT Next Year54.27%
EBIT Next 3Y23.8%
EBIT Next 5YN/A
FCF growth 1Y-141.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-88.72%
OCF growth 3Y-55.52%
OCF growth 5Y-26.51%